235 related articles for article (PubMed ID: 23437231)
1. Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development.
Green-Mitchell SM; Tersey SA; Cole BK; Ma K; Kuhn NS; Cunningham TD; Maybee NA; Chakrabarti SK; McDuffie M; Taylor-Fishwick DA; Mirmira RG; Nadler JL; Morris MA
PLoS One; 2013; 8(2):e56763. PubMed ID: 23437231
[TBL] [Abstract][Full Text] [Related]
2. Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes.
McDuffie M; Maybee NA; Keller SR; Stevens BK; Garmey JC; Morris MA; Kropf E; Rival C; Ma K; Carter JD; Tersey SA; Nunemaker CS; Nadler JL
Diabetes; 2008 Jan; 57(1):199-208. PubMed ID: 17940120
[TBL] [Abstract][Full Text] [Related]
3. 12-Lipoxygenase governs the innate immune pathogenesis of islet inflammation and autoimmune diabetes.
Kulkarni A; Pineros AR; Walsh MA; Casimiro I; Ibrahim S; Hernandez-Perez M; Orr KS; Glenn L; Nadler JL; Morris MA; Tersey SA; Mirmira RG; Anderson RM
JCI Insight; 2021 Jul; 6(14):. PubMed ID: 34128835
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 12/15-Lipoxygenase Protects Against β-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes.
Hernandez-Perez M; Chopra G; Fine J; Conteh AM; Anderson RM; Linnemann AK; Benjamin C; Nelson JB; Benninger KS; Nadler JL; Maloney DJ; Tersey SA; Mirmira RG
Diabetes; 2017 Nov; 66(11):2875-2887. PubMed ID: 28842399
[TBL] [Abstract][Full Text] [Related]
5. 15-Lipoxygenase worsens renal fibrosis, inflammation, and metabolism in a murine model of ureteral obstruction.
Montford JR; Bauer C; Rahkola J; Reisz JA; Floyd D; Hopp K; Soranno DE; Klawitter J; Weiser-Evans MCM; Nemenoff R; Faubel S; Furgeson SB
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F105-F119. PubMed ID: 34866403
[TBL] [Abstract][Full Text] [Related]
6. 12-lipoxygenase promotes obesity-induced oxidative stress in pancreatic islets.
Tersey SA; Maier B; Nishiki Y; Maganti AV; Nadler JL; Mirmira RG
Mol Cell Biol; 2014 Oct; 34(19):3735-45. PubMed ID: 25071151
[TBL] [Abstract][Full Text] [Related]
7. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice.
Bleich D; Chen S; Zipser B; Sun D; Funk CD; Nadler JL
J Clin Invest; 1999 May; 103(10):1431-6. PubMed ID: 10330425
[TBL] [Abstract][Full Text] [Related]
8. An apparent role for Alox15 in the pathogenesis of diabetes in the NOD mouse: parsing the supporting genetic data.
Weisberg SP; Leibel RL
Diabetes; 2008 Jan; 57(1):1-2. PubMed ID: 18165353
[No Abstract] [Full Text] [Related]
9. Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes.
Grzesik WJ; Nadler JL; Machida Y; Nadler JL; Imai Y; Morris MA
J Clin Endocrinol Metab; 2015 Mar; 100(3):E387-95. PubMed ID: 25532042
[TBL] [Abstract][Full Text] [Related]
10. 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet.
Nunemaker CS; Chen M; Pei H; Kimble SD; Keller SR; Carter JD; Yang Z; Smith KM; Wu R; Bevard MH; Garmey JC; Nadler JL
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1065-75. PubMed ID: 18780776
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of siAlox15 and sunitinib for reversing the new-onset of type 1 diabetes in non-obese diabetic mice.
Peng Y; Wen D; Lin F; Mahato RI
J Control Release; 2018 Dec; 292():1-12. PubMed ID: 30393183
[TBL] [Abstract][Full Text] [Related]
12. Platelet-type 12-lipoxygenase deletion provokes a compensatory 12/15-lipoxygenase increase that exacerbates oxidative stress in mouse islet β cells.
Conteh AM; Reissaus CA; Hernandez-Perez M; Nakshatri S; Anderson RM; Mirmira RG; Tersey SA; Linnemann AK
J Biol Chem; 2019 Apr; 294(16):6612-6620. PubMed ID: 30792307
[TBL] [Abstract][Full Text] [Related]
13. Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene.
Melanitou E
Gene; 2020 Aug; 753():144785. PubMed ID: 32445922
[TBL] [Abstract][Full Text] [Related]
14. Adipose tissue-specific deletion of 12/15-lipoxygenase protects mice from the consequences of a high-fat diet.
Cole BK; Morris MA; Grzesik WJ; Leone KA; Nadler JL
Mediators Inflamm; 2012; 2012():851798. PubMed ID: 23326022
[TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of interleukin-1beta in pancreatic islets of NOD mice during cyclophosphamide-accelerated diabetes: co-localization in macrophages and endocrine cells and its attenuation with oral nicotinamide.
Reddy S; Young M; Ginn S
Histochem J; 2001 Jun; 33(6):317-27. PubMed ID: 11758808
[TBL] [Abstract][Full Text] [Related]
16. Mice lacking macrophage 12/15-lipoxygenase are resistant to experimental hypertension.
Kriska T; Cepura C; Magier D; Siangjong L; Gauthier KM; Campbell WB
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(11):H2428-38. PubMed ID: 22467300
[TBL] [Abstract][Full Text] [Related]
17. Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes.
Leconet W; Petit P; Peraldi-Roux S; Bresson D
Mol Ther; 2012 Dec; 20(12):2315-25. PubMed ID: 22990670
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC
Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552
[TBL] [Abstract][Full Text] [Related]
19. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
20. Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages.
Wen Y; Gu J; Vandenhoff GE; Liu X; Nadler JL
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1933-8. PubMed ID: 18296557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
